HIGHLIGHTS
SUMMARY
Expanding access to the opioid antagonist naloxone is a safe and cost-effective method to reduce opioid overdose deaths, and there is evidence that expanding naloxone distribution significantly reduces community-level overdose mortality rates. While naloxone distribution should be prioritized for people who use illicit opioids, as they are most likely to witness and respond to overdoses, those who do not use opioids but may witness an overdose constitute an important target population for naloxone distribution as well. Massachusetts has demonstrated high rates of pharmacy-based naloxone access; a statewide phone survey showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.